The Limited Sensitivity of Chest Computed Tomography Relative to Reverse Transcription Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus-2 Infection: A Systematic Review on COVID-19 Diagnostics
- PMID: 32554983
- PMCID: PMC7314354
- DOI: 10.1097/RLI.0000000000000700
The Limited Sensitivity of Chest Computed Tomography Relative to Reverse Transcription Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus-2 Infection: A Systematic Review on COVID-19 Diagnostics
Abstract
Objectives: Several studies suggest the sensitivity of chest computed tomography (CT) is far greater than that of reverse transcription polymerase chain reaction (RT-PCR) in diagnosing COVID-19 patients, and therefore, CT should be included as a primary diagnostic tool. This systematic review aims to stratify studies as high or low risk of bias to determine the true sensitivity of CT for severe acute respiratory syndrome coronavirus-2 infection according to the unbiased (low risk) studies, a topic of particular importance given the insufficient quantity of RT-PCR kits in many countries. We focus on sensitivity as that is the chief advantage perceived of CT.
Materials and methods: This systematic review involved searching the PubMed and Google Scholar databases for articles conducted and published between January 1 and April 15, 2020. The quality assessment tool QUADAS-2 was used to stratify studies according to their risk of bias, and exclusion criteria included not providing the information deemed relevant for such a stratification, such as not indicating if the patients were symptomatic or asymptomatic, or identifying the source of the specimen for the reference standard, RT-PCR (eg, nasal, oropharyngeal, etc). Sensitivity values were then extracted, and random effects meta-analyses were performed.
Results: Of 641 search results, 37 studies (n = 9610 patients) were included in the analysis. The mean sensitivity of RT-PCR for COVID-19 reported by the biased studies was 70% (n = 5409/7 studies; 95% confidence interval [CI], 43-97; I = 99.1%), compared with 78% by unbiased studies (n = 534/4 studies; 95% CI, 69-87, I = 89.9%). For chest CT, the mean sensitivity reported by biased studies was 94% (n = 3371 patients/24 studies; 95% CI, 92-96; I = 93.1%), compared with 75% by unbiased studies (n = 957/10 studies; 95% CI, 67-83; I = 89.5%).
Conclusions: The difference between the sensitivities of CT and RT-PCR for severe acute respiratory syndrome coronavirus-2 infection is lower than previously thought, as after stratifying the studies, the true sensitivity for CT based on the unbiased studies is limited.
Conflict of interest statement
Conflicts of interest and sources of funding: none declared.
Figures



Similar articles
-
Thoracic imaging tests for the diagnosis of COVID-19.Cochrane Database Syst Rev. 2020 Sep 30;9:CD013639. doi: 10.1002/14651858.CD013639.pub2. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Nov 26;11:CD013639. doi: 10.1002/14651858.CD013639.pub3. PMID: 32997361 Updated.
-
A meta-analysis of accuracy and sensitivity of chest CT and RT-PCR in COVID-19 diagnosis.Sci Rep. 2020 Dec 28;10(1):22402. doi: 10.1038/s41598-020-80061-2. Sci Rep. 2020. PMID: 33372194 Free PMC article.
-
Thoracic imaging tests for the diagnosis of COVID-19.Cochrane Database Syst Rev. 2020 Nov 26;11:CD013639. doi: 10.1002/14651858.CD013639.pub3. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Mar 16;3:CD013639. doi: 10.1002/14651858.CD013639.pub4. PMID: 33242342 Updated.
-
Update on the limited sensitivity of computed tomography relative to RT-PCR for COVID-19: a systematic review.Pol J Radiol. 2022 Jul 12;87:e381-e391. doi: 10.5114/pjr.2022.118238. eCollection 2022. Pol J Radiol. 2022. PMID: 35979154 Free PMC article. Review.
-
Universal screening for SARS-CoV-2 infection: a rapid review.Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718. Cochrane Database Syst Rev. 2020. PMID: 33502003 Free PMC article.
Cited by
-
Co-relation of SARS-CoV-2 related 30-d mortality with HRCT score and RT-PCR Ct value-based viral load in patients with solid malignancy.World J Clin Oncol. 2022 May 24;13(5):339-351. doi: 10.5306/wjco.v13.i5.339. World J Clin Oncol. 2022. PMID: 35662981 Free PMC article.
-
Imaging in the COVID-19 era: Lessons learned during a pandemic.World J Radiol. 2021 Jun 28;13(6):192-222. doi: 10.4329/wjr.v13.i6.192. World J Radiol. 2021. PMID: 34249239 Free PMC article. Review.
-
The Main Molecular and Serological Methods for Diagnosing COVID-19: An Overview Based on the Literature.Viruses. 2020 Dec 29;13(1):40. doi: 10.3390/v13010040. Viruses. 2020. PMID: 33383888 Free PMC article. Review.
-
COVID-19; current situation and recommended interventions.Int J Clin Pract. 2021 May;75(5):e13886. doi: 10.1111/ijcp.13886. Epub 2021 Jan 14. Int J Clin Pract. 2021. PMID: 33278855 Free PMC article. Review.
-
Diagnostic performance of chest CT in screening patients with suspected COVID-19 infection in a Western population.Br J Radiol. 2020 Sep 1;93(1113):20200643. doi: 10.1259/bjr.20200643. Epub 2020 Aug 18. Br J Radiol. 2020. PMID: 32808545 Free PMC article.
References
-
- World Map. Centers for Disease Control and Prevention. 2020. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/world-map.html. Accessed April 19, 2020.
-
- Centers for Disease Control and Prevention. Cases in U.S. 2020. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html. Accessed April 19, 2020.
-
- Lippi G, Simundic AM, Plebani M. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19) [published online ahead of print]. Clin Chem Lab Med. - PubMed